Advanced Biological Laboratories   Report issue

For profit Phase 1 Phase 3
Founded: Luxembourg City Luxembourg (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2015
NCT02282176
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Advanced Biological Laboratories ABL (ABL SA) | Applied Biological Laboratories Inc

Active Ingredients

Drugs in Phase 3 Trials (2)

Key: Advanced Biological Laboratories (1) Acquired (1)

autologous culture chondrocytes (Carticel) (2 trials)

azithromycin (zithromax) (1 trial)

Drugs in Phase 1 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

nalbuphine (nubain) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchopulmonary Dysplasia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4